These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 32832675)

  • 21. Anti-interleukin-17 treatment of psoriasis.
    Jinna S; Strober B
    J Dermatolog Treat; 2016 Aug; 27(4):311-5. PubMed ID: 26943806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of concurrent target suppression by JNJ-61178104, a bispecific antibody against human tumor necrosis factor and interleukin-17A.
    Zheng S; Shen F; Jones B; Fink D; Geist B; Nnane I; Zhou Z; Hall J; Malaviya R; Ort T; Wang W
    MAbs; 2020; 12(1):1770018. PubMed ID: 32544369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-1β, IL-17A and combined phototherapy predicts higher while previous systemic biologic treatment predicts lower treatment response to etanercept in psoriasis patients.
    Liu Y; Qin G; Meng Z; Du T; Wang X; Tang Y; Cao J
    Inflammopharmacology; 2019 Feb; 27(1):57-66. PubMed ID: 30242748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TNFα siRNA delivery by nanoparticles and photochemical internalization for psoriasis topical therapy.
    Suzuki IL; de Araujo MM; Bagnato VS; Bentley MVLB
    J Control Release; 2021 Oct; 338():316-329. PubMed ID: 34437914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Keratinocyte overexpression of IL-17C promotes psoriasiform skin inflammation.
    Johnston A; Fritz Y; Dawes SM; Diaconu D; Al-Attar PM; Guzman AM; Chen CS; Fu W; Gudjonsson JE; McCormick TS; Ward NL
    J Immunol; 2013 Mar; 190(5):2252-62. PubMed ID: 23359500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
    Wang M; Zhang S; Zheng G; Huang J; Songyang Z; Zhao X; Lin X
    Immunity; 2018 Jul; 49(1):66-79.e5. PubMed ID: 29980436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CIKS/Act1-mediated signaling by IL-17 cytokines in context: implications for how a CIKS gene variant may predispose to psoriasis.
    Sønder SU; Paun A; Ha HL; Johnson PF; Siebenlist U
    J Immunol; 2012 Jun; 188(12):5906-14. PubMed ID: 22581863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psoriasis: rationale for targeting interleukin-17.
    Girolomoni G; Mrowietz U; Paul C
    Br J Dermatol; 2012 Oct; 167(4):717-24. PubMed ID: 22716185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Efficiency of Topical Calcipotriol/Betamethasone Treatment in Psoriasis Relies on Suppression of the Inflammatory TNFα - IL-23 - IL-17 Axis.
    Kubin ME; Kokkonen N; Palatsi R; Hägg PM; Väyrynen JP; Glumoff V; Haapasaari KM; Hurskainen T; Tasanen K
    Acta Derm Venereol; 2017 Apr; 97(4):449-455. PubMed ID: 27868150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of biologics in psoriasis.
    Kamata M; Tada Y
    J Dermatol; 2018 Mar; 45(3):279-286. PubMed ID: 29226369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nanostructured lipid carrier co-delivering tacrolimus and TNF-α siRNA as an innovate approach to psoriasis.
    Viegas JSR; Praça FG; Caron AL; Suzuki I; Silvestrini AVP; Medina WSG; Del Ciampo JO; Kravicz M; Bentley MVLB
    Drug Deliv Transl Res; 2020 Jun; 10(3):646-660. PubMed ID: 32060883
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-36γ sustains a proinflammatory self-amplifying loop with IL-17C in anti-TNF-induced psoriasiform skin lesions of patients with Crohn's disease.
    Friedrich M; Tillack C; Wollenberg A; Schauber J; Brand S
    Inflamm Bowel Dis; 2014 Nov; 20(11):1891-901. PubMed ID: 25299544
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies in the Treatment of Psoriasis: IL-12/23 p40 and IL-17a.
    Leonardi CL
    Semin Cutan Med Surg; 2016 Jun; 35(4 Suppl 4):S74-7. PubMed ID: 27551698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of interleukin (IL)-17A+ T lymphocytes and IL-17A expression in treatment-resistant psoriatic plaques despite ustekinumab therapy.
    Jack C; Mashiko S; Arbour N; Bissonnette R; Sarfati M
    Br J Dermatol; 2017 Jul; 177(1):267-270. PubMed ID: 27599204
    [No Abstract]   [Full Text] [Related]  

  • 35. A modern approach to the treatment of plaque psoriasis.
    Drvar DL; Vlahinić T; Maleš Ž; Turčić P; Čeović R
    Acta Pharm; 2019 Dec; 69(4):511-523. PubMed ID: 31639088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the Safety and Efficacy of Tumor Necrosis Factor Inhibitors and Interleukin-17 Inhibitors in Patients With Psoriasis.
    Green LJ; Yamauchi PS; Kircik LH
    J Drugs Dermatol; 2019 Aug; 18(8):776-788. PubMed ID: 31424708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I, randomized, double-blind study to assess the safety, tolerability and efficacy of the topical RORC2 inverse agonist PF-06763809 in participants with mild-to-moderate plaque psoriasis.
    Berstein G; Zhang Y; Berger Z; Kieras E; Li G; Samuel A; Yeoh T; Dowty H; Beaumont K; Wigger-Alberti W; von Mackensen Y; Kroencke U; Hamscho R; Garcet S; Krueger JG; Banfield C; Oemar B
    Clin Exp Dermatol; 2021 Jan; 46(1):122-129. PubMed ID: 32767679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Downregulation of Cathepsin B Reduces Proliferation and Inflammatory Response and Facilitates Differentiation in Human HaCaT Keratinocytes, Ameliorating IL-17A and SAA-Induced Psoriasis-Like Lesion.
    Xu D; Wang J
    Inflammation; 2021 Oct; 44(5):2006-2017. PubMed ID: 34037897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17A.
    Ruiz-Romeu E; Ferran M; Giménez-Arnau A; Bugara B; Lipert B; Jura J; Florencia EF; Prens EP; Celada A; Pujol RM; Santamaria-Babí LF
    J Invest Dermatol; 2016 Aug; 136(8):1599-1607. PubMed ID: 27180111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secukinumab for treating plaque psoriasis.
    Rothstein B; Gottlieb A
    Expert Opin Biol Ther; 2016; 16(1):119-28. PubMed ID: 26577956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.